Skip to Main content Skip to Navigation
Journal articles

Mycobacterial virulence: impact on immunogenicity and vaccine research

Abstract : The borderline between virulence and efficacy in live attenuated vaccine strains is often blurred and this is also the case for the Bacillus Calmette-Guérin (BCG), the only currently licensed anti-tuberculosis vaccine used on a large, global scale, which was obtained almost 100 years ago. While BCG is more than 99% identical at the genome level to Mycobacterium tuberculosis, the causative pathogen of human tuberculosis, some important differences in virulence factors cause naturally irreversible attenuation and safety of this vaccine in the immunocompetent host. Some of these virulence factors are involved in persistence capacities of the vaccine strains and also represent strong immunogens, responsible for inducing different host signaling pathways, which have to be taken into consideration for the development of revised and new vaccine strains. Here we discuss a number of selected mycobacterial features in relation to their biological functions and potential impact on virulence and vaccine efficacy.
Document type :
Journal articles
Complete list of metadatas

Cited literature [51 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-02615238
Contributor : Fadel Sayes <>
Submitted on : Friday, May 22, 2020 - 12:11:43 PM
Last modification on : Friday, June 5, 2020 - 4:23:36 AM

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Vera Kroesen, Jan Madacki, Wafa Frigui, Fadel Sayes, Roland Brosch. Mycobacterial virulence: impact on immunogenicity and vaccine research. F1000Research, Faculty of 1000, 2019, 8, pp.2025. ⟨10.12688/f1000research.20572.1⟩. ⟨pasteur-02615238⟩

Share

Metrics

Record views

36

Files downloads

55